Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Brain. 2019 Aug 1;142(8):2483-2491. doi: 10.1093/brain/awz162.
Although white matter hyperintensities have traditionally been viewed as a marker of vascular disease, recent pathology studies have found an association between white matter hyperintensities and Alzheimer's disease pathologies. The objectives of this study were to investigate the topographic patterns of white matter hyperintensities associated with Alzheimer's disease biomarkers measured using PET. From the population-based Mayo Clinic Study of Aging, 434 participants without dementia (55% male) with FLAIR and gradient recall echo MRI, tau-PET (AV-1451) and amyloid-PET scans were identified. A subset had cerebral microbleeds detected on T2* gradient recall echo scans. White matter hyperintensities were semi-automatically segmented using FLAIR MRI in participant space and normalized to a custom template. We used statistical parametric mapping 12-based, voxel-wise, multiple-regression analyses to detect white matter hyperintense regions associated with Alzheimer's biomarkers (global amyloid from amyloid-PET and meta-regions of interest tau uptake from tau-PET) after adjusting for age, sex and hypertension. For amyloid associations, we additionally adjusted for tau and vice versa. Topographic patterns of amyloid-associated white matter hyperintensities included periventricular white matter hyperintensities (frontal and parietal lobes). White matter hyperintense volumes in the detected topographic pattern correlated strongly with lobar cerebral microbleeds (P < 0.001, age and sex adjusted Cohen's d = 0.703). In contrast, there were no white matter hyperintense regions significantly associated with increased tau burden using voxel-based analysis or region-specific analysis. Among non-demented elderly, amyloid load correlated with a topographic pattern of white matter hyperintensities. Further, the amyloid-associated, white matter hyperintense regions strongly correlated with lobar cerebral microbleeds suggesting that cerebral amyloid angiopathy contributes to the relationship between amyloid and white matter hyperintensities. The study did not support an association between increased tau burden and white matter hyperintense burden.
虽然脑白质高信号一直被认为是血管疾病的标志物,但最近的病理学研究发现,脑白质高信号与阿尔茨海默病病理之间存在关联。本研究的目的是探讨使用 PET 测量阿尔茨海默病生物标志物时与阿尔茨海默病相关的脑白质高信号的拓扑模式。从基于人群的梅奥诊所衰老研究中,确定了 434 名无痴呆(55%为男性)参与者,他们具有 FLAIR 和梯度回波 MRI、tau-PET(AV-1451)和淀粉样蛋白-PET 扫描。一部分人在 T2*梯度回波扫描中检测到脑微出血。使用 FLAIR MRI 在参与者空间中半自动分割脑白质高信号,并将其归一化为自定义模板。我们使用基于统计参数映射 12 的体素-wise、多元回归分析,在调整年龄、性别和高血压后,检测与阿尔茨海默病生物标志物(淀粉样蛋白-PET 的全局淀粉样蛋白和 tau-PET 的感兴趣区 tau 摄取)相关的脑白质高信号区域。对于淀粉样蛋白相关性,我们还分别调整了 tau,反之亦然。与淀粉样蛋白相关的脑白质高信号的拓扑模式包括脑室周围脑白质高信号(额叶和顶叶)。在检测到的拓扑模式中,脑白质高信号体积与脑叶性脑微出血强烈相关(P < 0.001,年龄和性别调整后的 Cohen's d = 0.703)。相比之下,使用基于体素的分析或区域特异性分析,没有发现与 tau 负担增加显著相关的脑白质高信号区域。在非痴呆的老年人中,淀粉样蛋白负荷与脑白质高信号的拓扑模式相关。此外,与淀粉样蛋白相关的脑白质高信号区域与脑叶性脑微出血强烈相关,这表明脑淀粉样血管病导致了淀粉样蛋白与脑白质高信号之间的关系。该研究不支持 tau 负担增加与脑白质高信号负担之间的关联。